Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS)
Clinical trial NCT04032158 · TERMINATED
Trial details
- NCT number
- NCT04032158
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-26
- Primary completion
- 2020-04-16
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.